CDH2 and non-small cell lung carcinoma: Therefore, we further explored the changes in EMT-related proteins in 19-HB-treated NSCLC cells; the results showed that 19-HB decreased the expression of the mesenchymal markers N-cadherin and Vimentin, while the epithelial marker ZO-1 was increased.